Examqo

Examqo › Examqo library › Cardiothoracic surgery › Benign and end-stage lung disease · IMLE

Lung transplantation — the basics

Lung transplantation is for a patient with end-stage lung disease who is expected to die from it despite optimal treatment and has no contraindications; the main indications are ILD (mostly IPF), COPD, CF and PAH, the lethal early complication is primary graft dysfunction, and the main late complication is chronic rejection (CLAD/BOS).

Why it matters in the exam

The exam asks when to refer, who is not a candidate, which type of transplant fits and which complication fits the period. In ILD referral is early — already at diagnosis of IPF — because the disease progresses fast; in COPD the BODE index is used, and referral fits from a BODE of 5 or more. In CF and bronchiectasis a bilateral transplant is mandatory, because a remaining infected lung would contaminate the graft. Contraindications according to ISHLT 2021 include active or recent cancer, a BMI of 35 or more, active smoking or substance use, uncontrolled infection, significant failure of another organ and non-adherence.

Complications by time: in the first 72 hours — primary graft dysfunction (PGD), non-cardiogenic pulmonary oedema and impaired oxygenation; in the first weeks — bronchial anastomotic complications (because the bronchial arteries are not reconnected), acute rejection diagnosed by transbronchial biopsy, and infections (CMV is the commonest opportunistic infection, and also Aspergillus). Late — chronic rejection (CLAD), defined as a persistent fall of 20% or more in FEV1 from the best baseline value, and the leading cause of death after the first year; and post-transplant lymphoproliferative disease (PTLD) linked to EBV. Typical immunosuppression combines tacrolimus, mycophenolate and steroids, and median survival is only about 6 years — lower than after other organ transplants.

Remember also that a patient with severe PAH and irreversible right heart failure may need a heart-lung transplant. After transplant the patient stays under close lifelong follow-up, with home spirometry and periodic tests, to detect rejection and infection early.

Key points

Summary table

PeriodComplicationKey points
First 72 hoursPrimary graft dysfunction (PGD)Main cause of early death
First weeksBronchial anastomotic complicationNo bronchial arterial supply
First monthsAcute rejectionTransbronchial biopsy; steroids
Any timeInfections — CMV, AspergillusProphylaxis and monitoring
LateCLAD/BOSA fall of 20% or more in FEV1; leading cause of late death

A free exam question

בת 55, כחודש לאחר השתלת כליה. מתאשפזת עם עליה בקריאטנין מ- 0.9 מ"ג/ד"ל ל- 2.5 מ"ג/ד"ל ופרוטאינוריה חדשה. בביופסיה Acute cellular rejection . בדם נמצאו רמות שפל של Tacrolimus מתחת לסף הגילוי. מה יכולה להיות הסיבה הסבירה ביותר ? (the question as examined, in Hebrew)

  1. א. התחלת טיפול ב- Verapamil בשבועיים האחרונים בשל פרפור פרוזדורים
  2. ב. חידוש טיפול ב- Carbamazepine שהופסק סביב ניתוח ההשתלה
  3. ג. טיפול ב- Erythromycin לפני שבוע בשל דימום ממערכת העיכול העליונה
  4. ד. טיפול ב- Ketoconazole לפני שבוע לזיהום פטרייתי בציפורניים

See the answer and explanation

In the full version for subscribers

The full version is open to subscribers of: Cardiothoracic surgery, General surgery, Internal medicine, Medical licensing exam (IMLE).

Subscriber? Read the full topic Plans and prices 25 free questions

Sources

Sources are given for further reading; the text is written afresh and not copied from them.

Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.